Literature DB >> 10217914

Urticaria and angioedema: diagnostic and treatment considerations.

S A Kumar1, B L Martin.   

Abstract

Urticaria and angioedema are common--and commonly frustrating--problems for physicians and patients alike. Patients often are in considerable distress with pruritus and uncomfortable lesions. They are frightened about their condition and frustrated when modern medicine cannot pinpoint the cause of the symptoms. Both urticaria and angioedema may be categorized as acute and chronic conditions. The dividing line between acute and chronic forms is relatively arbitrarily set at 6 weeks. A thorough history and physical examination may provide clues to the underlying cause, but in the majority of patients, the cause is rarely identified. One is more likely to discover the cause of acute than of chronic urticaria. A multitude of laboratory tests can be performed, but they often do not provide a diagnosis. It is not appropriate to do a large "screening" battery of laboratory tests. The dermal mast cells and their mediators play a central role in chronic urticaria. Chronic urticaria may have an autoimmune aspect. Recent evidence reveals that 50% of patients with chronic urticaria have a cutaneous autoimmune disorder mediated by autoantibodies to the high-affinity IgE receptor on mast cells. Biopsy may be necessary and may help with treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10217914

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  4 in total

1.  Immune aberrations in B and T lymphocytes derived from chronic urticaria patients.

Authors:  E Toubi; A Adir-Shani; A Kessel; Z Shmuel; E Sabo; H Hacham
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

Review 2.  Does dehydroepiandrosterone influence the expression of urticaria?-a mini review.

Authors:  A Kasperska-Zajac
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

3.  Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?

Authors:  Atıl Avcı; Deniz Avcı; Ragip Ertas; Mustafa Atasoy; Cigdem Karakukcu; Efşan Yontar; Yilmaz Ulas; Kemal Ozyurt
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

4.  Determination of dermatology life quality index, and serum C-reactive protein and plasma interleukin-6 levels in patients with chronic urticaria.

Authors:  Derya Ucmak; Meltem Akkurt; Gülten Toprak; Yavuz Yesilova; Enver Turan; Ismail Yıldız
Journal:  Postepy Dermatol Alergol       Date:  2013-06-20       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.